OncoSil Medical Limited (ASX:OSL) Completes PANCOSIL Study Recruitment
OncoSil Medical (ASX:OSL) completes patient recruitment for the PANCOSIL study, advancing its clinical development of pancreatic cancer treatment.
Category: ASX-OSL
ONCOSIL MEDICAL LTD
OncoSil Medical Limited (ASX:OSL) Announces $8.7M Capital Raise to Drive Commercialisation
OncoSil Medical (ASX:OSL) secures $8.7 million in capital to advance commercialisation and support ongoing clinical trials.
ONCOSIL MEDICAL LTD (ASX:OSL) Announces Security Consolidation
ONCOSIL MEDICAL LTD (ASX:OSL) announces a 400-to-1 security consolidation, outlining the consolidation ratio, timetable, and impact on securities.